ARCHIVES

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 12 | March 23, 1994

Download PDF Visit The Full Archive

Related Articles

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

NCAB Committee Close To Definition Of QRA

February 11, 1983

PDF file includes 8-page February issue of Business & Regulatory Report.

February 27, 2004

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

Colorado Center Delays New Core Grant Application

July 13, 1979